Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02861300
Title CB-839 + Capecitabine in Solid Tumors and Fluoropyrimidine Resistant PIK3CA Mutant Colorectal Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Case Comprehensive Cancer Center

colorectal cancer

Advanced Solid Tumor


Capecitabine + Telaglenastat

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST